Market Tracker

06/24 5:16pm ET

Cytokinetics Inc (NASDAQ:CYTK)

9.04
Delayed Data
As of Jun 24
 +0.05 / +0.56%
Today’s Change
5.88
Today|||52-Week Range
13.18
-13.58%
Year-to-Date

Today’s Trading

Previous close8.99
Today’s open8.49
Day’s range8.06 - 9.34
Volume1,074,992
Average volume (3 months)340,225
Market cap$358.2M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-54.98%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book5.22

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...-1.72-9.31%
NUTRNutraceutical Intern...-0.59-2.50%
RIGLRigel Pharmaceutical...-0.16-6.48%
NATRNatures Sunshine Pro...-0.04-0.39%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts